| 臺大學術典藏 |
2022-08-12T06:29:20Z |
Serum lymphocyte subpopulations and immunoglobulins in gastric cancer patients: A comparative study between earlier and more advanced stages
|
Lee J.-C.; Lin P.-W.; Huang S.-M.; Tsao C.-J.; Lai H.-S.; KING-JEN CHANG |
| 臺大學術典藏 |
2022-06-27T07:07:55Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; CHONG-JEN YU; Chang W.-C.; Kuo H.-P.; Yu C.-T.; Lin Z.-Z.; Kao W.-Y. |
| 臺大學術典藏 |
2022-06-10T06:11:15Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 國立成功大學 |
2022 |
Role of high ubiquitin‑conjugating enzyme E2 expression as a prognostic factor in nasopharyngeal carcinoma
|
Kao, W.-C.;Hsu, S.-H.;Lin, C.-L.;Lin, C.-Y.;Chen, S.-W.;Chen, Y.-X.;Chen, Chen C.-H.;Lee, S.-W.;Tsao, C.-J.;Huang, W.-T.;Chen, S.-H.;Hsiao, S.-Y. |
| 臺大學術典藏 |
2021-09-01T02:02:42Z |
Weekly CAF chemotherapy for advanced breast cancer patients
|
Hwang W.-S.; Hsiung C.A.; Ko W.-S.; lVang C.-C.; Chang J.-V.; Lai G.-M.; Hsieh R.-K.; Tsao C.-J.; Chen L.-T.; Law C.-K.; ANN-LII CHENG; Fan S.F.; Tzeng C.-H.; Chiou T.-J.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:25Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
ANN-LII CHENG; Hsiung C.A.; Su I.-J.; Chen P.-J.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-09-01T02:02:14Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T01:54:24Z |
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
|
ANN-LII CHENG; Kang Y.-K.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Luo R.; Feng J.; Ye S.; Yang T.-S.; Xu J.; Sun Y.; Liang H.; Liu J.; Wang J.; Tak W.Y.; Pan H.; Burock K.; Zou J.; Voliotis D.; Guan Z. |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
|
ANN-LII CHENG; Guan Z.; Chen Z.; Tsao C.-J.; Qin S.; Kim J.S.; Yang T.-S.; Tak W.Y.; Pan H.; Yu S.; Xu J.; Fang F.; Zou J.; Lentini G.; Voliotis D.; Kang Y.-K. |
| 臺大學術典藏 |
2021-08-11T03:46:52Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Perng R.-P.; Yang C.-H.; Chen Y.-M.; Chang G.-C.; Lin M.-C.; Hsieh R.-K.; Chu N.-M.; Lai R.-S.; Su W.-C.; Tsao C.-J.; Hsia T.-C.; Chen H.-C.; Chen C.-H.; Huang M.-S.; Wang J.-L.; Ho M.-L.; Chung C.-Y.; Yu C.-J.; Chang W.-C.; Kuo H.-P.; Yu C.-T.; ZHONG-ZHE LIN; Kao W.-Y. |
| 臺大學術典藏 |
2021-07-03T03:35:40Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng A.-L.; Hsiung C.A.; Su I.-J.; PEI-JER CHEN; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2021-07-03T03:35:21Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-05-26T09:08:28Z |
Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside - The Taiwan experience
|
YAO-CHANG CHEN; Lin S.-F.; Yao M.; Chen T.-Y.; Tsao C.-J.; Chen T.-P. |
| 臺大學術典藏 |
2021-01-05T03:35:02Z |
Induction therapy of newly diagnosed acute nonlymphocytic leukemia with idarubicin and cytosine arabinoside - The Taiwan experience
|
Chen T.-P.; Tsao C.-J.; Chen T.-Y.; MING YAO; Lin S.-F.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-04T12:13:01Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Whang-Peng J.; Chen L.-T.; HWEI-FANG TIEN; Chao T.-Y.; Hsu C.-H.; Uen W.-C.; Kao W.-Y.; Tsao C.-J.; Chang M.-C.; Chen P.-J.; Su I.-J.; Cheng A.-L.; Hsiung C.A. |
| 國立成功大學 |
2021 |
Age as a modifier of the effects of chemoradiotherapy with infusional 5-fluorouracil after D2 dissection in gastric cancer
|
Wu, H.-C.;Lin, W.-L.;Lin, C.-L.;Lin, C.-Y.;Chen, S.-W.;Chen, Y.-X.;Chen, Chen C.-H.;Lee, S.-W.;Chen, S.-H.;Tsao, C.-J.;Huang, W.-T.;Guo, H.-R. |
| 國立成功大學 |
2021 |
Colorectal Cancer with EML4-ALK Fusion Gene Response to Alectinib: A Case Report and Review of the Literature
|
Hsiao, S.-Y.;He, He H.-L.;Weng, T.-S.;Lin, C.-Y.;Chao, Chao C.-M.;Huang, W.-T.;Tsao, C.-J. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study
|
Botwood N; Thatcher N.; Watkins C; Tsao C.-J; CHIH-HSIN YANG; Ganzon D; Perng R.-P; Tan E.H; Thongprasert S; Parikh P; Chang A; Chang A;Parikh P;Thongprasert S;Tan E.H;Perng R.-P;Ganzon D;Chih-Hsin Yang;Tsao C.-J;Watkins C;Botwood N;Thatcher N. |
| 臺大學術典藏 |
2020-05-26T09:27:22Z |
High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy
|
Kao W.-Y.;Lin Z.-Z;Yu C.-T;Kuo H.-P;Chang W.-C;Yu C.-J;Chung C.-Y;Ho M.-L;Wang J.-L;Huang M.-S;Chen C.-H;Chen H.-C;Hsia T.-C;Tsao C.-J;Su W.-C;Lai R.-S;Chu N.-M;Hsieh R.-K;Lin M.-C;Chang G.-C;Chen Y.-M;Chih-Hsin Yang;Perng R.-P; Perng R.-P; CHIH-HSIN YANG; Chen Y.-M; Chang G.-C; Lin M.-C; Hsieh R.-K; Chu N.-M; Lai R.-S; Su W.-C; Tsao C.-J; Hsia T.-C; Chen H.-C; Chen C.-H; Huang M.-S; Wang J.-L; Ho M.-L; Chung C.-Y; Yu C.-J; Chang W.-C; Kuo H.-P; Yu C.-T; Lin Z.-Z; Kao W.-Y. |
| 臺大學術典藏 |
2020-05-25T07:35:27Z |
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
|
Abou-Alfa G.K; Chan S.L; Chia-Chi Lin; Chiorean E.G; Holcombe R.F; Mulcahy M.F; Carter W.D; Patel K; Wilson W.R; Melink T.J; Gutheil J.C; Tsao C.-J. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P;Wen C.-C;Hsiung C.A;Su I.-J;Cheng A.-L;Chang M.-C;Tsao C.-J;Kao W.-Y;Uen W.-C;Hsu C.-H;Yen-Shen Lu;Tien H.-F;Chao T.-Y;Chen L.-T;Whang-Peng J;Chen P.-J.; Su W.-P; Wen C.-C; Hsiung C.A; Su I.-J; Cheng A.-L; Chang M.-C; Tsao C.-J; Kao W.-Y; Uen W.-C; Hsu C.-H; YEN-SHEN LU; Tien H.-F; Chao T.-Y; Chen L.-T; Whang-Peng J; Chen P.-J. |
| 臺大學術典藏 |
2020-04-28T07:25:37Z |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng A.-L.;Hsiung C.A.;Su I.-J.;Chen P.-J.;Chang M.-C.;Tsao C.-J.;Kao W.-Y.;Uen W.-C.;Chih-Hung Hsu;Tien H.-F.;Chao T.-Y.;Chen L.-T.;Whang-Peng J.; Cheng A.-L.; Hsiung C.A.; Su I.-J.; Chen P.-J.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; CHIH-HUNG HSU; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J. |
| 臺大學術典藏 |
2020-02-24T05:14:22Z |
Serum lymphocyte subpopulations and immunoglobulins in gastric cancer patients: A comparative study between earlier and more advanced stages
|
Lee J.-C.;Lin P.-W.;Huang S.-M.;Tsao C.-J.;Hong-Shiee Lai;Chang K.-J.; Lee J.-C.; Lin P.-W.; Huang S.-M.; Tsao C.-J.; HONG-SHIEE LAI; Chang K.-J. |
| 國立成功大學 |
2019 |
Expression of prothymosin α in lung cancer is associated with squamous cell carcinoma and smoking
|
Kuo, Y.-.H.;Shiau, A.-L.;Tung, C.-L.;Su, Y.-C.;Li, C.-F.;Su, B.-H.;Tsao, C.-J.;Wu, C.-L.;Feng, Y.-H.;Wu, P. |
| 國立成功大學 |
2019 |
Proteomic profile of sorafenib resistance in hepatocellular carcinoma; GRP78 expression is associated with inferior response to sorafenib
|
Feng, Y.-H.;Tung, C.-L.;Su, Y.-C.;Tsao, C.-J.;Wu, T.-F. |
